Impact of baseline NS5A polymorphisms on sustained virologic response in patients infected with HCV treated with daclatasvir-based regimens
United States and Asia, for the treatment of HCV. In patients infected with HCV, response rates to DCV-based regimens can depend on the regimen, GT, and pre-treatment nonstructural ... RAPs) to DCV. The effects of NS5A…

